- All sections
- C - Chemistrymetallurgy
- C07F - Acyclic, carbocyclic, or heterocyclic compounds containing elements other than carbon, hydrogen, halogen, oxygen, nitrogen, sulfur, selenium or tellurium
- C07F 9/60 - Quinoline or hydrogenated quinoline ring systems
Patent holdings for IPC class C07F 9/60
Total number of patents in this class: 80
10-year publication summary
|
7
|
4
|
9
|
3
|
3
|
3
|
2
|
5
|
1
|
4
|
| 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
Principal owners for this class
| Owner |
All patents
|
This class
|
|---|---|---|
| Debiopharm International SA | 131 |
4 |
| The Regents of the University of California | 19929 |
3 |
| University of South Florida | 1830 |
3 |
| Ardelyx, Inc. | 113 |
3 |
| Biogen MA Inc. | 892 |
3 |
| China Medical University | 133 |
3 |
| Enzo Life Sciences, Inc. | 162 |
3 |
| Nagasaki University | 204 |
3 |
| Dow Silicones Corporation | 1929 |
3 |
| Lunella Biotech, Inc. | 104 |
3 |
| The Board of Trustees of the Leland Stanford Junior University | 6416 |
2 |
| Beijing Konruns Pharmaceutical Co., Ltd. | 15 |
2 |
| Enzo Biochem, Inc. | 126 |
2 |
| Kaneq Pharma Inc. | 4 |
2 |
| Tairx, Inc. | 5 |
2 |
| Kanyr Pharma Inc. | 4 |
2 |
| Novartis AG | 10850 |
1 |
| Bristol-myers Squibb Company | 4893 |
1 |
| Bayer AG | 3331 |
1 |
| Bayer Pharma AG | 1047 |
1 |
| Other owners | 33 |